Company Filing History:
Years Active: 2020
Title: Kiran Lata: Innovator in Cancer Therapy
Introduction
Kiran Lata is a prominent inventor based in Uttar Pradesh, India. She has made significant contributions to the field of medical science, particularly in the treatment of chronic myeloid leukemia (CML). Her innovative approach combines existing therapies to enhance treatment efficacy for patients suffering from drug-resistant forms of this disease.
Latest Patents
Kiran Lata holds a patent for her invention titled "Combination of clofazimine and imatinib for effective therapy of drug-resistant myeloid leukemia." This patent describes a method for treating chronic myeloid leukemia by administering a therapeutically effective amount of Clofazimine or its derivatives, either alone or in combination with a tyrosine kinase inhibitor. The invention also includes a kit designed for the treatment of CML or drug-resistant CML. She has 1 patent to her name.
Career Highlights
Kiran Lata is affiliated with the Council of Scientific & Industrial Research, where she conducts her research and development activities. Her work focuses on innovative solutions to combat challenging medical conditions, particularly in oncology.
Collaborations
Kiran collaborates with esteemed colleagues such as Sabyasachi Sanyal and Harish Kumar, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kiran Lata's contributions to cancer therapy exemplify the impact of innovative thinking in medicine. Her work not only advances scientific knowledge but also offers hope to patients facing difficult health challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.